Newron Pharmaceuticals SpA's total assets for Q2 2024 were €24.94M, a decrease of -3.59% from the previous quarter. NWPHF total liabilities were €55.77M for the fiscal quarter, a >-0.01% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.